Sam’s Club pharmacies are now selling Novo Nordisk’s Ozempic and Wegovy for $499 per month, expanding consumer access to the popular GLP-1 drugs used for diabetes and weight loss.
The retailer joins Costco, GoodRx and Novo Nordisk’s NovoCare Pharmacy in offering the same discounted price, according to an Oct. 8 report from USA Today. Wegovy’s list price is $1,349 for a month of doses.
Novo Nordisk is broadening retail access as more insurers expand GLP-1 drug coverage. In 2024, 44% of large employers covered GLP-1 drugs for obesity, up from 41% the year before.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.